Need Help?

Evaluation of capture and amplicon-based targeted sequencing methods on formalin-fixed tumours

Three capture (Agilent’s SureSelectXT HS, Illumina’s Nextera Rapid Capture Custom, and New England Biolabs’ Next Direct Custom) and one amplicon-based (Qiagen’s Human Breast Cancer Panel) targeted sequencing methods on 6-8 paired blood and FFPE from the Malaysian Breast Cancer Cohort.

Request Access

Access to controlled data will follow the guidelines provided by the International Cancer Genome Consortium, subject to the Malaysian Personal Data Protection Act.

Access to controlled data will follow the guidelines provided by the International Cancer Genome Consortium. All individual-level sequence data stored on the EGA are controlled and requires the review of the Data Access Committee before access is permitted, to protect patient privacy. All aggregate data and data that cannot be used to re-identify individuals are considered open, and are accessible through the relevant publications. Given that all patients in the cohort are Malaysian, data access is further subject to the Malaysian Personal Data Protection Act and its various prohibitions.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004965 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00004973448 bam 256.9 MB Report
EGAF00004973449 bam 143.8 MB Report
EGAF00004973450 bam 226.3 MB Report
EGAF00004973451 bam 135.8 MB Report
EGAF00004973452 bam 188.2 MB Report
EGAF00004973453 bam 215.0 MB Report
EGAF00004973454 bam 271.1 MB Report
EGAF00004973455 bam 166.2 MB Report
EGAF00004973456 bam 222.1 MB Report
EGAF00004973457 bam 147.3 MB Report
EGAF00004973458 bam 212.7 MB Report
EGAF00004973459 bam 132.7 MB Report
EGAF00004973460 bam 274.5 MB Report
EGAF00004973461 bam 185.0 MB Report
EGAF00004973462 bam 240.4 MB Report
EGAF00004973463 bam 136.3 MB Report
EGAF00004973464 bam 545.8 MB Report
EGAF00004973465 bam 228.6 MB Report
EGAF00004973466 bam 193.5 MB Report
EGAF00004973467 bam 179.5 MB Report
EGAF00004973468 bam 175.1 MB Report
EGAF00004973469 bam 216.2 MB Report
EGAF00004973470 bam 279.0 MB Report
EGAF00004973471 bam 169.9 MB Report
EGAF00004973472 bam 200.1 MB Report
EGAF00004973473 bam 305.7 MB Report
EGAF00004973474 bam 159.9 MB Report
EGAF00004973475 bam 204.8 MB Report
EGAF00004973476 bam 155.8 MB Report
EGAF00004973477 bam 170.0 MB Report
EGAF00004973478 bam 178.9 MB Report
EGAF00004973479 bam 171.3 MB Report
EGAF00004973480 bam 176.3 MB Report
EGAF00004973481 bam 187.7 MB Report
EGAF00004973482 bam 185.2 MB Report
EGAF00004973483 bam 176.0 MB Report
EGAF00004973484 bam 173.4 MB Report
EGAF00004973485 bam 231.9 MB Report
EGAF00004973486 bam 183.0 MB Report
EGAF00004973487 bam 169.6 MB Report
EGAF00004973488 bam 178.3 MB Report
EGAF00004973489 bam 171.3 MB Report
EGAF00004973490 bam 190.4 MB Report
EGAF00004973491 bam 177.2 MB Report
EGAF00004973492 bam 209.2 MB Report
EGAF00004973493 bam 176.2 MB Report
EGAF00004973494 bam 81.6 MB Report
EGAF00004973495 bam 257.7 MB Report
EGAF00004973496 bam 209.7 MB Report
EGAF00004973497 bam 203.5 MB Report
EGAF00004973498 bam 163.6 MB Report
EGAF00004973499 bam 196.6 MB Report
EGAF00004973500 bam 71.8 MB Report
EGAF00004973501 bam 283.1 MB Report
EGAF00004973502 bam 29.9 MB Report
EGAF00004973503 bam 252.2 MB Report
56 Files (11.0 GB)